Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-02

Clinical Trial Update: Texture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel Diseases [NA]

View source ↗

Summary

A University of Ulm clinical study is evaluating Texture and Color Enhancement Imaging (TXI) as a noninvasive way to assess inflammation in inflammatory bowel d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Ulm | Conditions: Inflammatory Bowel Diseases, Colitis, Ulcerative | NA | Status: RECRUITING